Serge Saxonov 10x Genomics, Inc. (TXG) insider trading activity

Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 882,467 shares of TXG, which is worth approximately $20.3 Million. The most recent transaction as insider was on Jun 14, 2023, when has been sold 185 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 882K

0.76% 3M change

2.74% 12M change

Total Value Held $20.3 Million

Serge Saxonov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 14 2023	SELL Bona fide gift	-	185 Reduced 0.02%	893,005 Class A Common Stock
May 23 2023	SELL Open market or private sale	$143,266 $55.06 p/Share	2,602 Reduced 0.29%	893,190 Class A Common Stock
May 15 2023	SELL Open market or private sale	$106,280 $53.14 p/Share	2,000 Reduced 0.22%	895,792 Class A Common Stock
Apr 14 2023	SELL Open market or private sale	$109,020 $54.51 p/Share	2,000 Reduced 0.22%	897,792 Class A Common Stock
Mar 21 2023	BUY Grant, award, or other acquisition	-	36,387 Added 3.89%	899,792 Class A Common Stock
Mar 14 2023	SELL Open market or private sale	$98,100 $49.05 p/Share	2,000 Reduced 0.23%	863,405 Class A Common Stock
Feb 22 2023	SELL Open market or private sale	$92,682 $47.75 p/Share	1,941 Reduced 0.21%	909,715 Class A Common Stock
Dec 12 2022	BUY Exercise of conversion of derivative security	$3,600 $1.2 p/Share	3,000 Added 0.33%	911,656 Class A Common Stock
Nov 22 2022	SELL Open market or private sale	$91,171 $34.07 p/Share	2,676 Reduced 0.27%	974,926 Class A Common Stock
Sep 12 2022	BUY Exercise of conversion of derivative security	$13,800 $1.2 p/Share	11,500 Added 1.16%	977,602 Class A Common Stock
Aug 23 2022	SELL Open market or private sale	$95,541 $35.19 p/Share	2,715 Reduced 0.28%	966,102 Class A Common Stock
May 23 2022	SELL Open market or private sale	$129,507 $48.76 p/Share	2,656 Reduced 0.27%	968,817 Class A Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	58,731 Added 5.7%	971,473 Class A Common Stock
Feb 22 2022	SELL Open market or private sale	$43,309 $78.6 p/Share	551 Reduced 0.06%	912,742 Class A Common Stock
Feb 08 2022	SELL Open market or private sale	$1,076,160 $89.68 p/Share	12,000 Reduced 1.3%	913,293 Class A Common Stock
Feb 08 2022	BUY Exercise of conversion of derivative security	$34,876 $11.48 p/Share	3,038 Added 0.33%	925,293 Class A Common Stock
Jan 04 2022	SELL Open market or private sale	$2,131,200 $142.08 p/Share	15,000 Reduced 1.6%	922,255 Class A Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$34,865 $11.48 p/Share	3,037 Added 0.32%	937,255 Class A Common Stock
Dec 28 2021	BUY Exercise of conversion of derivative security	$67,636 $1.2 p/Share	56,363 Added 5.69%	934,218 Class A Common Stock
Dec 07 2021	SELL Open market or private sale	$2,171,850 $144.79 p/Share	15,000 Reduced 1.68%	877,855 Class A Common Stock
Dec 07 2021	BUY Exercise of conversion of derivative security	$68,112 $8.26 p/Share	8,246 Added 0.92%	892,855 Class A Common Stock
Nov 22 2021	SELL Open market or private sale	$114,549 $148.38 p/Share	772 Reduced 0.09%	884,609 Class A Common Stock
Nov 02 2021	SELL Open market or private sale	$2,424,000 $161.6 p/Share	15,000 Reduced 1.67%	885,381 Class A Common Stock
Nov 02 2021	BUY Exercise of conversion of derivative security	$68,104 $8.26 p/Share	8,245 Added 0.91%	900,381 Class A Common Stock
Oct 05 2021	SELL Open market or private sale	$2,165,400 $144.36 p/Share	15,000 Reduced 1.65%	892,136 Class A Common Stock

Serge Saxonov

Chief Executive Officer

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account